Fitbit vs. hospital ECG: can a smartwatch save hearts?
NCT ID NCT06887387
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is testing whether a Fitbit can accurately measure heart electrical activity (QT interval) in 80 adults with Long QT Syndrome, a condition that can cause dangerous heart rhythms. Participants will use a Fitbit to take weekly ECG readings at home, which will be compared to standard hospital ECGs. The goal is to see if wearable devices can reliably track heart health and help explain symptoms, potentially reducing the need for frequent clinic visits.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LONG QT SYNDROME are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Barts and London Hospital NHS Trust
RECRUITINGLondon, United Kingdom
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Heart conditions in kids: study reveals impact on daily life and play
- AI trained on 127,000 ECGs to predict deadly heart rhythms
- Simple cheek swab could predict sudden cardiac death risk
- Should doctors call your family? study tests best way to screen for genetic risks
- Hormone shield: could progesterone or testosterone guard against Drug-Induced heart risks?
- Which heart device lead lasts longest in kids? study aims to find out